Watson settles with Janssen over Ortho Tri-Cyclen LO


US generic drugmaker Watson Pharmaceutical (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

GenericsJanssenJohnson & JohnsonLegalNorth AmericaPatentsReproductiveWatson PharmaceuticalsWomen's Health

FDA panel mixed on Ortho Evra


The majority of members of the US Food and Drug Administration’s Reproductive Health Drugs Advisory…

Johnson & JohnsonNorth AmericaOrtho EvraPharmaceuticalRegulationReproductiveWomen's Health

Bayer buys rights to “female Viagra” for C$330 million; Johnson & Johnson proceeds with $2.42 billion bid for Crucell


Bayer HealthCare Pharmaceuticals, a unit of Germany’s Bayer (BAY: DE) has entered into an accord…

BayerCrucellEndoCeuticsJohnson & JohnsonLicensingMergers & AcquisitionsPharmaceuticalReproductiveVaccinesVaginorm

Bayer says US filing for Xarelto delayed; Visanne cleared in Europe


German drug major Bayer announced over the weekend details of data from the EINSTEIN Extension study…

AspirinBayerBayerCardio-vascularEuropeJohnson & JohnsonNorth AmericaNystatinOralPharmaceuticalRegulationReproductive

Back to top